Merck & Co. (MRK)
(Real Time Quote from BATS)
$127.64 USD
+0.70 (0.55%)
Updated Apr 23, 2024 09:41 AM ET
3-Hold of 5 3
C Value D Growth B Momentum C VGM
Detailed Estimates
EPS Estimates
Earnings Date | *BMO4/25/24 |
---|---|
Current Quarter | 1.98 |
EPS Last Quarter | 0.03 |
Last EPS Surprise | 133.33% |
ABR | 1.42 |
Earnings ESP
|
-1.36% |
---|---|
Current Year | 8.59 |
Next Year | 9.89 |
EPS (TTM) | 1.50 |
P/E (F1) | 14.78 |
Sales Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 15.32B | 16.00B | 64.17B | 68.79B |
# of Estimates | 7 | 7 | 7 | 7 |
High Estimate | 15.67B | 16.38B | 65.29B | 71.62B |
Low Estimate | 15.01B | 15.76B | 63.08B | 66.60B |
Year ago Sales | 14.49B | 15.04B | 60.11B | 64.17B |
Year over Year Growth Est. | 5.76% | 6.42% | 6.74% | 7.21% |
Earnings Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 1.98 | 2.16 | 8.59 | 9.89 |
# of Estimates | 8 | 7 | 11 | 9 |
Most Recent Consensus | 2.07 | 1.96 | 8.70 | 9.62 |
High Estimate | 2.25 | 2.27 | 8.78 | 10.50 |
Low Estimate | 1.80 | 1.96 | 8.44 | 9.60 |
Year ago EPS | 1.40 | -2.06 | 1.51 | 8.59 |
Year over Year Growth Est. | 41.43% | 204.85% | 468.87% | 15.20% |
Agreement - Estimate Revisions
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 2 | 1 | 2 |
Up Last 30 Days | 1 | 6 | 5 | 5 |
Up Last 60 Days | 1 | 6 | 6 | 6 |
Down Last 7 Days | 1 | 0 | 0 | 0 |
Down Last 30 Days | 5 | 0 | 3 | 1 |
Down Last 60 Days | 5 | 0 | 3 | 1 |
Magnitude - Consensus Estimate Trend
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | 1.98 | 2.16 | 8.59 | 9.89 |
7 Days Ago | 2.01 | 2.09 | 8.57 | 9.83 |
30 Days Ago | 2.12 | 1.96 | 8.58 | 9.81 |
60 Days Ago | 2.13 | 1.96 | 8.53 | 9.71 |
90 Days Ago | 1.99 | 2.04 | 8.49 | 9.49 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | 1.96 | 2.19 | 8.63 | 9.97 |
Zacks Consensus Estimate | 1.98 | 2.16 | 8.59 | 9.89 |
Earnings ESP | -1.36% | 1.54% | 0.47% | 0.81% |
Surprise - Reported Earnings History
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Quarter Ending (3/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | 0.03 | 2.13 | -2.06 | 1.40 | NA |
Estimate | -0.09 | 1.94 | -2.17 | 1.34 | NA |
Difference | 0.12 | 0.19 | 0.11 | 0.06 | 0.12 |
Surprise | 133.33% | 9.79% | 5.07% | 4.48% | 38.17% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more